CASI Pharmaceuticals, Inc. (CASI) Form 6-K — Aug 13, 2026

CASI Pharmaceuticals announced that Wei (Larry) Zhang will no longer serve as Senior Vice President of the Company, per a Form 6-K filed August 13, 2026. The departure was made in connection with the Company's previously announced efforts to streamline its branches, personnel and related activities in the United States, suggesting continued cost and footprint reduction.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.